Integra Lifesciences Holdings Corp financial data

Symbol
IART on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1100 Campus Road, Princeton, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INTEGRA LIFESCIENCES CORP (to 3/31/1999)
Latest financial report
10-Q - Q2 2024 - Jul 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 357 % +3.27%
Quick Ratio 122 % +17.1%
Debt-to-equity 149 % +23%
Return On Equity 1.5 % -80.3%
Return On Assets 0.6 % -82.6%
Operating Margin 4.06 % -65.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.6M shares -4.7%
Entity Public Float 3.26B USD -16.8%
Common Stock, Value, Issued 916K USD +0.77%
Weighted Average Number of Shares Outstanding, Basic 77.4M shares -4.39%
Weighted Average Number of Shares Outstanding, Diluted 77.4M shares -4.61%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.57B USD +1.37%
Costs and Expenses 1.5B USD +10.2%
Operating Income (Loss) 63.6M USD -65%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 27.1M USD -82.7%
Income Tax Expense (Benefit) 3.4M USD -86.6%
Net Income (Loss) Attributable to Parent 23.6M USD -82%
Earnings Per Share, Basic 0.3 USD/shares -81.3%
Earnings Per Share, Diluted 0.3 USD/shares -80.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 215M USD -30.4%
Accounts Receivable, after Allowance for Credit Loss, Current 271M USD +4.83%
Inventory, Net 422M USD +19%
Other Assets, Current 28.8M USD
Assets, Current 1.11B USD +5.81%
Deferred Income Tax Assets, Net 45.8M USD -18.4%
Property, Plant and Equipment, Net 374M USD +17.6%
Operating Lease, Right-of-Use Asset 147M USD -0.79%
Intangible Assets, Net (Excluding Goodwill) 1.22B USD +11.6%
Goodwill 1.1B USD +5.88%
Other Assets, Noncurrent 70.8M USD +5.39%
Assets 4.07B USD +7.86%
Employee-related Liabilities, Current 69.6M USD +7.67%
Accrued Liabilities, Current 102M USD +8.4%
Contract with Customer, Liability, Current 9.91M USD +19.7%
Liabilities, Current 328M USD -13%
Contract with Customer, Liability, Noncurrent 8.4M USD -1.18%
Deferred Income Tax Liabilities, Net 86.5M USD +22.5%
Operating Lease, Liability, Noncurrent 170M USD +6.28%
Other Liabilities, Noncurrent 155M USD +0.97%
Liabilities 2.54B USD +21.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -18.7M USD -488%
Retained Earnings (Accumulated Deficit) 931M USD +2.61%
Stockholders' Equity Attributable to Parent 1.53B USD -8.85%
Liabilities and Equity 4.07B USD +7.86%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15.8M USD -39.8%
Net Cash Provided by (Used in) Financing Activities 359M USD
Net Cash Provided by (Used in) Investing Activities -54M USD -294%
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 91.6M shares +0.78%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 316M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 215M USD -30.4%
Deferred Tax Assets, Valuation Allowance 12.5M USD +29.4%
Deferred Tax Assets, Gross 240M USD +13.8%
Operating Lease, Liability 184M USD +5.75%
Payments to Acquire Property, Plant, and Equipment 15.5M USD +12.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 92K USD -99.9%
Lessee, Operating Lease, Liability, to be Paid 273M USD +4.1%
Property, Plant and Equipment, Gross 708M USD +10.4%
Operating Lease, Liability, Current 14.6M USD -0.03%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.7M USD +2.67%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.8M USD +6.42%
Deferred Income Tax Expense (Benefit) -2.86M USD -246%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 89M USD +0.83%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.4M USD +11.3%
Deferred Tax Assets, Operating Loss Carryforwards 28.8M USD -6.21%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 812K USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.3M USD +0.71%
Operating Lease, Payments 5.73M USD +32.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20.1M USD +56.5%
Deferred Tax Assets, Net of Valuation Allowance 227M USD +13%
Interest Expense 52.9M USD +5.72%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares